BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang LT, Liu KJ, Sytwu HK, Yen ML, Yen BL. Advances in mesenchymal stem cell therapy for immune and inflammatory diseases: Use of cell-free products and human pluripotent stem cell-derived mesenchymal stem cells. Stem Cells Transl Med 2021;10:1288-303. [PMID: 34008922 DOI: 10.1002/sctm.21-0021] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
Number Citing Articles
1 Liang Q, Li Q, Ren B, Yin ZQ. Intravenous infusion of small umbilical cord mesenchymal stem cells could enhance safety and delay retinal degeneration in RCS rats. BMC Ophthalmol 2022;22:67. [PMID: 35144581 DOI: 10.1186/s12886-021-02171-3] [Reference Citation Analysis]
2 Wang LT, Liu KJ, Sytwu HK, Yen ML, Yen BL. Advances in mesenchymal stem cell therapy for immune and inflammatory diseases: Use of cell-free products and human pluripotent stem cell-derived mesenchymal stem cells. Stem Cells Transl Med 2021;10:1288-303. [PMID: 34008922 DOI: 10.1002/sctm.21-0021] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
3 Martinez-arroyo O, Ortega A, Forner MJ, Cortes R. Mesenchymal Stem Cell-Derived Extracellular Vesicles as Non-Coding RNA Therapeutic Vehicles in Autoimmune Diseases. Pharmaceutics 2022;14:733. [DOI: 10.3390/pharmaceutics14040733] [Reference Citation Analysis]
4 Li C, Zhao H, Cheng L, Wang B. Allogeneic vs. autologous mesenchymal stem/stromal cells in their medication practice. Cell Biosci 2021;11:187. [PMID: 34727974 DOI: 10.1186/s13578-021-00698-y] [Reference Citation Analysis]
5 Ma KS, Lee CC, Liu KJ, Wei JC, Lee YT, Wang LT. Safety and Seroconversion of Immunotherapies against SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis of Clinical Trials. Pathogens 2021;10:1537. [PMID: 34959492 DOI: 10.3390/pathogens10121537] [Reference Citation Analysis]
6 Tang Y, Wu P, Li L, Xu W, Jiang J. Mesenchymal Stem Cells and Their Small Extracellular Vesicles as Crucial Immunological Efficacy for Hepatic Diseases. Front Immunol 2022;13:880523. [DOI: 10.3389/fimmu.2022.880523] [Reference Citation Analysis]
7 Zeng L, Yu G, Yang K, Xiang W, Li J, Chen H, Mishra R. Efficacy and Safety of Mesenchymal Stem Cell Transplantation in the Treatment of Autoimmune Diseases (Rheumatoid Arthritis, Systemic Lupus Erythematosus, Inflammatory Bowel Disease, Multiple Sclerosis, and Ankylosing Spondylitis): A Systematic Review and Meta-Analysis of Randomized Controlled Trial. Stem Cells International 2022;2022:1-20. [DOI: 10.1155/2022/9463314] [Reference Citation Analysis]
8 Chen JM, Huang QY, Zhao YX, Chen WH, Lin S, Shi QY. The Latest Developments in Immunomodulation of Mesenchymal Stem Cells in the Treatment of Intrauterine Adhesions, Both Allogeneic and Autologous. Front Immunol 2021;12:785717. [PMID: 34868069 DOI: 10.3389/fimmu.2021.785717] [Reference Citation Analysis]
9 Terai S, Tsuchiya A, Watanabe Y, Takeuchi S. Transition of clinical and basic studies on liver cirrhosis treatment using cells to seek the best treatment. Inflamm Regen 2021;41:27. [PMID: 34530931 DOI: 10.1186/s41232-021-00178-3] [Reference Citation Analysis]
10 Zhou L, Shen M, Fan X, Liu Y, Yang L. Pathogenic and Potential Therapeutic Roles of Exosomes Derived From Immune Cells in Liver Diseases. Front Immunol 2022;13:810300. [DOI: 10.3389/fimmu.2022.810300] [Reference Citation Analysis]
11 Wang LT, Yen BL, Wang HH, Chao YY, Lee W, Huang LY, Chiu SK, Siu LK, Liu KJ, Sytwu HK, Yen ML. Placental mesenchymal stem cells boost M2 alveolar over M1 bone marrow macrophages via IL-1β in Klebsiella-mediated acute respiratory distress syndrome. Thorax 2022:thoraxjnl-2021-217928. [PMID: 35450943 DOI: 10.1136/thoraxjnl-2021-217928] [Reference Citation Analysis]
12 Matheakakis A, Batsali A, Papadaki HA, Pontikoglou CG. Therapeutic Implications of Mesenchymal Stromal Cells and Their Extracellular Vesicles in Autoimmune Diseases: From Biology to Clinical Applications. Int J Mol Sci 2021;22:10132. [PMID: 34576296 DOI: 10.3390/ijms221810132] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Nazimek K, Bryniarski K. Increasing the Therapeutic Efficacy of Extracellular Vesicles From the Antigen-Specific Antibody and Light Chain Perspective. Front Cell Dev Biol 2021;9:790722. [PMID: 34901032 DOI: 10.3389/fcell.2021.790722] [Reference Citation Analysis]